시장조사 보고서 : 세계의 소분자 종양 표적화 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Targeting Small Molecule Tumor Drugs Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02196 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 소분자 종양 표적화 약물 의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (티로신인산화 효소 억제제, 히스톤탈아세틸라아제 억제제, 라파마이신 억제제 표적)와 용도별 시장규모 (병원, 클리닉, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 소분자 종양 표적화 약물 시장 점유율
- 지역별 소분자 종양 표적화 약물 시장규모
- 주요지역의 종류별 시장규모 (티로신인산화 효소 억제제, 히스톤탈아세틸라아제 억제제, 라파마이신 억제제 표적)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 기타)
- 미주의 소분자 종양 표적화 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 소분자 종양 표적화 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 소분자 종양 표적화 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 소분자 종양 표적화 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 소분자 종양 표적화 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
AstraZeneca, Novartis, Bayer, Roche, Pfizer, Beida Pharma, Bristol-Meyer Squibb, Qilu Pharma
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Targeting Small Molecule Tumor Drugs will have significant change from previous year. By the most conservative estimates of global Targeting Small Molecule Tumor Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Targeting Small Molecule Tumor Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeting Small Molecule Tumor Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Tyrosine Kinase Inhibitor
Histone Deacetylase Inhibitor
Target of Rapamycin Inhibitor

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Novartis
Bayer
Roche
Pfizer
Beida Pharma
Bristol-Meyer Squibb
Qilu Pharma

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeting Small Molecule Tumor Drugs Market Size 2016-2026
2.1.2 Targeting Small Molecule Tumor Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Targeting Small Molecule Tumor Drugs Segment by Type
2.2.1 Tyrosine Kinase Inhibitor
2.2.2 Tyrosine Kinase Inhibitor
2.2.3 Target of Rapamycin Inhibitor
2.3 Targeting Small Molecule Tumor Drugs Market Size by Type
2.3.1 Global Targeting Small Molecule Tumor Drugs Market Size CAGR by Type
2.3.2 Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
2.4 Targeting Small Molecule Tumor Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Targeting Small Molecule Tumor Drugs Market Size by Application
2.5.1 Global Targeting Small Molecule Tumor Drugs Market Size CAGR by Application
2.5.2 Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)

3 Targeting Small Molecule Tumor Drugs Market Size by Players
3.1 Targeting Small Molecule Tumor Drugs Market Size Market Share by Players
3.1.1 Global Targeting Small Molecule Tumor Drugs Revenue by Players (2019-2021E)
3.1.2 Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Players (2019-2021E)
3.2 Global Targeting Small Molecule Tumor Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Targeting Small Molecule Tumor Drugs by Regions
4.1 Targeting Small Molecule Tumor Drugs Market Size by Regions (2016-2021)
4.2 Americas Targeting Small Molecule Tumor Drugs Market Size Growth (2016-2021)
4.3 APAC Targeting Small Molecule Tumor Drugs Market Size Growth (2016-2021)
4.4 Europe Targeting Small Molecule Tumor Drugs Market Size Growth (2016-2021)
4.5 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth (2016-2021)

5 Americas
5.1 Americas Targeting Small Molecule Tumor Drugs Market Size by Country (2016-2021)
5.2 Americas Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021)
5.3 Americas Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Targeting Small Molecule Tumor Drugs Market Size by Region (2016-2021)
6.2 APAC Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021)
6.3 APAC Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Targeting Small Molecule Tumor Drugs by Country (2016-2021)
7.2 Europe Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021)
7.3 Europe Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Targeting Small Molecule Tumor Drugs by Region (2016-2021)
8.2 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021)
8.3 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Targeting Small Molecule Tumor Drugs Market Forecast
10.1 Global Targeting Small Molecule Tumor Drugs Forecast by Regions (2021-2026)
10.1.1 Global Targeting Small Molecule Tumor Drugs Forecast by Regions (2021-2026)
10.1.2 Americas Targeting Small Molecule Tumor Drugs Forecast
10.1.3 APAC Targeting Small Molecule Tumor Drugs Forecast
10.1.4 Europe Targeting Small Molecule Tumor Drugs Forecast
10.1.5 Middle East & Africa Targeting Small Molecule Tumor Drugs Forecast
10.2 Americas Targeting Small Molecule Tumor Drugs Forecast by Countries (2021-2026)
10.2.1 United States Targeting Small Molecule Tumor Drugs Market Forecast
10.2.2 Canada Targeting Small Molecule Tumor Drugs Market Forecast
10.2.3 Mexico Targeting Small Molecule Tumor Drugs Market Forecast
10.2.4 Brazil Targeting Small Molecule Tumor Drugs Market Forecast
10.3 APAC Targeting Small Molecule Tumor Drugs Forecast by Region (2021-2026)
10.3.1 China Targeting Small Molecule Tumor Drugs Market Forecast
10.3.2 Japan Targeting Small Molecule Tumor Drugs Market Forecast
10.3.3 Korea Targeting Small Molecule Tumor Drugs Market Forecast
10.3.4 Southeast Asia Targeting Small Molecule Tumor Drugs Market Forecast
10.3.5 India Targeting Small Molecule Tumor Drugs Market Forecast
10.3.6 Australia Targeting Small Molecule Tumor Drugs Market Forecast
10.4 Europe Targeting Small Molecule Tumor Drugs Forecast by Country (2021-2026)
10.4.1 Germany Targeting Small Molecule Tumor Drugs Market Forecast
10.4.2 France Targeting Small Molecule Tumor Drugs Market Forecast
10.4.3 UK Targeting Small Molecule Tumor Drugs Market Forecast
10.4.4 Italy Targeting Small Molecule Tumor Drugs Market Forecast
10.4.5 Russia Targeting Small Molecule Tumor Drugs Market Forecast
10.5 Middle East & Africa Targeting Small Molecule Tumor Drugs Forecast by Region (2021-2026)
10.5.1 Egypt Targeting Small Molecule Tumor Drugs Market Forecast
10.5.2 South Africa Targeting Small Molecule Tumor Drugs Market Forecast
10.5.3 Israel Targeting Small Molecule Tumor Drugs Market Forecast
10.5.4 Turkey Targeting Small Molecule Tumor Drugs Market Forecast
10.5.5 GCC Countries Targeting Small Molecule Tumor Drugs Market Forecast
10.6 Global Targeting Small Molecule Tumor Drugs Forecast by Type (2021-2026)
10.7 Global Targeting Small Molecule Tumor Drugs Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Targeting Small Molecule Tumor Drugs Product Offered
11.1.3 AstraZeneca Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Targeting Small Molecule Tumor Drugs Product Offered
11.2.3 Novartis Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Targeting Small Molecule Tumor Drugs Product Offered
11.3.3 Bayer Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Targeting Small Molecule Tumor Drugs Product Offered
11.4.3 Roche Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Targeting Small Molecule Tumor Drugs Product Offered
11.5.3 Pfizer Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Beida Pharma
11.6.1 Beida Pharma Company Information
11.6.2 Beida Pharma Targeting Small Molecule Tumor Drugs Product Offered
11.6.3 Beida Pharma Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Beida Pharma Main Business Overview
11.6.5 Beida Pharma Latest Developments
11.7 Bristol-Meyer Squibb
11.7.1 Bristol-Meyer Squibb Company Information
11.7.2 Bristol-Meyer Squibb Targeting Small Molecule Tumor Drugs Product Offered
11.7.3 Bristol-Meyer Squibb Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Bristol-Meyer Squibb Main Business Overview
11.7.5 Bristol-Meyer Squibb Latest Developments
11.8 Qilu Pharma
11.8.1 Qilu Pharma Company Information
11.8.2 Qilu Pharma Targeting Small Molecule Tumor Drugs Product Offered
11.8.3 Qilu Pharma Targeting Small Molecule Tumor Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Qilu Pharma Main Business Overview
11.8.5 Qilu Pharma Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Targeting Small Molecule Tumor Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Tyrosine Kinase Inhibitor
Table 3. Major Players of Histone Deacetylase Inhibitor
Table 4. Major Players of Target of Rapamycin Inhibitor
Table 5. Targeting Small Molecule Tumor Drugs Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
Table 8. Targeting Small Molecule Tumor Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)
Table 11. Global Targeting Small Molecule Tumor Drugs Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Players (2019-2021E)
Table 13. Targeting Small Molecule Tumor Drugs Key Players Head office and Products Offered
Table 14. Targeting Small Molecule Tumor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeting Small Molecule Tumor Drugs Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Regions 2016-2021
Table 19. Americas Targeting Small Molecule Tumor Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Country (2016-2021)
Table 21. Americas Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
Table 23. Americas Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)
Table 25. APAC Targeting Small Molecule Tumor Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Region (2016-2021)
Table 27. APAC Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
Table 29. APAC Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)
Table 31. Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Country (2016-2021)
Table 33. Europe Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
Table 35. Europe Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Targeting Small Molecule Tumor Drugs
Table 44. Key Application and Potential Industries of Targeting Small Molecule Tumor Drugs
Table 45. Key Challenges of Targeting Small Molecule Tumor Drugs
Table 46. Key Trends of Targeting Small Molecule Tumor Drugs
Table 47. Global Targeting Small Molecule Tumor Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Targeting Small Molecule Tumor Drugs Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Targeting Small Molecule Tumor Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Targeting Small Molecule Tumor Drugs Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Targeting Small Molecule Tumor Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Targeting Small Molecule Tumor Drugs Market Size Market Share Forecast by Application (2021-2026)
Table 53. AstraZeneca Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 54. AstraZeneca Targeting Small Molecule Tumor Drugs Product Offered
Table 55. AstraZeneca Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Novartis Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 59. Novartis Targeting Small Molecule Tumor Drugs Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Novartis Latest Developments
Table 63. Bayer Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 64. Bayer Targeting Small Molecule Tumor Drugs Product Offered
Table 65. Bayer Main Business
Table 66. Bayer Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Bayer Latest Developments
Table 68. Roche Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 69. Roche Targeting Small Molecule Tumor Drugs Product Offered
Table 70. Roche Main Business
Table 71. Roche Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Roche Latest Developments
Table 73. Pfizer Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 74. Pfizer Targeting Small Molecule Tumor Drugs Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Pfizer Latest Developments
Table 78. Beida Pharma Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 79. Beida Pharma Targeting Small Molecule Tumor Drugs Product Offered
Table 80. Beida Pharma Main Business
Table 81. Beida Pharma Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Beida Pharma Latest Developments
Table 83. Bristol-Meyer Squibb Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 84. Bristol-Meyer Squibb Targeting Small Molecule Tumor Drugs Product Offered
Table 85. Bristol-Meyer Squibb Main Business
Table 86. Bristol-Meyer Squibb Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Bristol-Meyer Squibb Latest Developments
Table 88. Qilu Pharma Details, Company Type, Targeting Small Molecule Tumor Drugs Area Served and Its Competitors
Table 89. Qilu Pharma Targeting Small Molecule Tumor Drugs Product Offered
Table 90. Qilu Pharma Main Business
Table 91. Qilu Pharma Targeting Small Molecule Tumor Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Qilu Pharma Latest Developments
List of Figures
Figure 1. Targeting Small Molecule Tumor Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeting Small Molecule Tumor Drugs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Type in 2020
Figure 7. Targeting Small Molecule Tumor Drugs in Hospital
Figure 8. Global Targeting Small Molecule Tumor Drugs Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Targeting Small Molecule Tumor Drugs in Clinic
Figure 10. Global Targeting Small Molecule Tumor Drugs Market: Clinic (2016-2021) & ($ Millions)
Figure 11. Targeting Small Molecule Tumor Drugs in Other
Figure 12. Global Targeting Small Molecule Tumor Drugs Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Application in 2020
Figure 14. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Player in 2020
Figure 15. Global Targeting Small Molecule Tumor Drugs Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Targeting Small Molecule Tumor Drugs Market Size 2016-2021 ($ Millions)
Figure 17. APAC Targeting Small Molecule Tumor Drugs Market Size 2016-2021 ($ Millions)
Figure 18. Europe Targeting Small Molecule Tumor Drugs Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size 2016-2021 ($ Millions)
Figure 20. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Country in 2020
Figure 21. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Type in 2020
Figure 22. Americas Targeting Small Molecule Tumor Drugs Market Size Market Share by Application in 2020
Figure 23. United States Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Regions in 2020
Figure 27. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Type in 2020
Figure 28. APAC Targeting Small Molecule Tumor Drugs Market Size Market Share by Application in 2020
Figure 29. China Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Country in 2020
Figure 36. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Type in 2020
Figure 37. Europe Targeting Small Molecule Tumor Drugs Market Size Market Share by Application in 2020
Figure 38. Germany Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Market Share by Application in 2020
Figure 46. Egypt Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Targeting Small Molecule Tumor Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 52. APAC Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 53. Europe Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 55. United States Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 56. Canada Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 59. China Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 60. Japan Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 61. Korea Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 63. India Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 64. Australia Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 65. Germany Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 66. France Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 67. UK Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 68. Italy Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 69. Russia Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 70. Spain Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 73. Israel Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Targeting Small Molecule Tumor Drugs Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 소분자 종양 표적화 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02196) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 소분자 종양 표적화 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 백금 항암제 시장예측 2021년-2026년
LPI-2201K02152 / LP Information / 2021년 12월 / 본 조사보고서는 백금 항암제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Platinum Anti-tumor Drugs will have significant change from previous year. By the most conservative estimates of global Platinum Anti-tumor Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 불임 치료제 시장예측 2021년-2026년
LPI-2201K00069 / LP Information / 2021년 12월 / 본 조사보고서는 불임 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Infertility Drugs will have significant change from previous year. By the most conservative estimates of global Infertility Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4687.8 million in 2020. Over...

세계의 주사제용 멸균 필 피니시 시장예측 2021년-2026년
LPI-2201K02310 / LP Information / 2021년 12월 / 본 조사보고서는 주사제용 멸균 필 피니시의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Sterile Fill-Finish For Injection Drugs will have significant change from previous year. By the most conservative estimates of global Sterile Fill-Finish For Injection Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 일로프로스트 약물 시장예측 2021년-2026년
LPI-2201K00058 / LP Information / 2021년 12월 / 본 조사보고서는 일로프로스트 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Iloprost Drugs will have significant change from previous year. By the most conservative estimates of global Iloprost Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 90 million in 2020. Over...